These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7691242)

  • 1. Compound heterozygosity for hemoglobin C and Korle-Bu: moderate microcytic hemolytic anemia and acceleration of crystal formation [corrected].
    Nagel RL; Lin MJ; Witkowska HE; Fabry ME; Bestak M; Hirsch RE
    Blood; 1993 Sep; 82(6):1907-12. PubMed ID: 7691242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acceleration of hemoglobin C crystallization by hemoglobin S.
    Lin MJ; Nagel RL; Hirsch RE
    Blood; 1989 Oct; 74(5):1823-5. PubMed ID: 2790206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HbC compound heterozygotes [HbC/Hb Riyadh and HbC/Hb N-Baltimore] with opposing effects upon HbC crystallization.
    Hirsch RE; Witkowska HE; Shafer F; Lin MJ; Balazs TC; Bookchin RM; Nagel RL
    Br J Haematol; 1997 May; 97(2):259-65. PubMed ID: 9163585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compound heterozygosity for hemoglobin C and hemoglobin Korle-Bu.
    Kossover CL; Eckman JR; Young AN
    Lab Hematol; 2008; 14(3):30-4. PubMed ID: 18812284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular interactions between Hb alpha-G Philadelphia, HbC, and HbS: phenotypic implications for SC alpha-G Philadelphia disease.
    Lawrence C; Hirsch RE; Fataliev NA; Patel S; Fabry ME; Nagel RL
    Blood; 1997 Oct; 90(7):2819-25. PubMed ID: 9326250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential pathways in oxy and deoxy HbC aggregation/crystallization.
    Hirsch RE; Samuel RE; Fataliev NA; Pollack MJ; Galkin O; Vekilov PG; Nagel RL
    Proteins; 2001 Jan; 42(1):99-107. PubMed ID: 11093264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical and hematological profile of Lepore Hemoglobin in Ivory Coast].
    Sangare A; Sanogo I; Meite M; Segbena A; Toure AH; Elenga JP; Siransy L; Allangba O
    Med Trop (Mars); 1994; 54(1):43-6. PubMed ID: 8196525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mild Microcytic Anemia in an Infant with a Compound Heterozygosity for Hb C (HBB: c.19G > A) and Hb Osu Christiansborg (HBB: c.157G > A).
    Boucher MO; Chui DH; Woda BA; Newburger PE
    Hemoglobin; 2016 Jun; 40(3):208-9. PubMed ID: 27117572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The inhibition of hemoglobin C crystallization by hemoglobin F.
    Hirsch RE; Lin MJ; Nagel RL
    J Biol Chem; 1988 Apr; 263(12):5936-9. PubMed ID: 2451674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compound heterozygosity for Hb Korle-Bu (beta(73); Asp-Asn) and Hb E (beta(26); Glu-Lys) with a 3.7-kb deletional alpha-thalassemia in Thai patients.
    Changtrakun Y; Fucharoen S; Ayukarn K; Siriratmanawong N; Fucharoen G; Sanchaisuriya K
    Ann Hematol; 2002 Jul; 81(7):389-93. PubMed ID: 12185510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunochemical properties of abnormal hemoglobins C-Harlem (beta 6 Glu replaced by Val, beta 73 Asp replaced by Asn), S (beta 6 Glu replaced by Val), Korle Bu (beta 73 Asp replaced by Asn), Vancouver (beta 73 Asp replaced by Tyr), and Mobile (beta 73 Asp replaced by Val).
    Garver FA; Baker MM; Grenett HE
    Biochim Biophys Acta; 1980 Jul; 624(1):286-92. PubMed ID: 7407239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The paradox of hemoglobin SC disease.
    Nagel RL; Fabry ME; Steinberg MH
    Blood Rev; 2003 Sep; 17(3):167-78. PubMed ID: 12818227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complex interaction of Hb E [beta26(B8)Glu-->Lys], Hb Korle-Bu [beta73(E17)Asp-->Asn] and a deletional alpha-thalassemia-1 in pregnancy.
    Siriratmanawong N; Chansri W; Singsanan S; Fucharoen G; Fucharoen S
    Hemoglobin; 2009; 33(6):507-14. PubMed ID: 19958198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase separation and crystallization of hemoglobin C in transgenic mouse and human erythrocytes.
    Canterino JE; Galkin O; Vekilov PG; Hirsch RE
    Biophys J; 2008 Oct; 95(8):4025-33. PubMed ID: 18621841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The unique red cell heterogeneity of SC disease: crystal formation, dense reticulocytes, and unusual morphology.
    Lawrence C; Fabry ME; Nagel RL
    Blood; 1991 Oct; 78(8):2104-12. PubMed ID: 1912587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HbS-oman heterozygote: a new dominant sickle syndrome.
    Nagel RL; Daar S; Romero JR; Suzuka SM; Gravell D; Bouhassira E; Schwartz RS; Fabry ME; Krishnamoorthy R
    Blood; 1998 Dec; 92(11):4375-82. PubMed ID: 9834244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hemoglobin C (alpha 2 beta 2 6Glu-->lys). Study of 19 heterozygote AC carriers and of 5 cases of double hemoglobinopathy SC].
    De Caluwé JP; Alexander M; Bondue H
    Acta Clin Belg; 1993; 48(5):297-306. PubMed ID: 8291338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical and laboratory spectrum of Hb C [β6(A3)Glu→Lys, GAG>AAG] disease.
    Cook CM; Smeltzer MP; Mortier NA; Kirk SE; Despotovic JM; Ware RE; Hankins JS
    Hemoglobin; 2013; 37(1):16-25. PubMed ID: 23297836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPLC-ESI-MS/MS analysis of hemoglobin peptides in tryptic digests of dried-blood spot extracts detects HbS, HbC, HbD, HbE, HbO-Arab, and HbG-Philadelphia mutations.
    Haynes CA; Guerra SL; Fontana JC; DeJesús VR
    Clin Chim Acta; 2013 Sep; 424():191-200. PubMed ID: 23796846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the beta 73 amino acid on the hydrophobicity, solubility, and the kinetics of polymerization of deoxyhemoglobin S.
    Adachi K; Kim J; Kinney TR; Asakura T
    J Biol Chem; 1987 Aug; 262(22):10470-4. PubMed ID: 3611079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.